Manufacturer record
Zest Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Zest Pharma (Madhya Pradesh) were declared Not of Standard Quality between December 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T6229, Cefixime Tablets I.P. 200 mg (exp Jun 2028). SDTL, Punjab (state lab) found it not of standard quality: Description. Listed in the September 2026 alert.
Records by type
10 records linked to Zest Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime Tablets I.P. 200 mg | Batch T6229Mfg Jul 2026 · Exp Jun 2028 | DescriptionDescription | SDTL, PunjabState lab | Sep 2026 |
| Cefixime Tablets I.P. 200 mg | Batch T6228Mfg Jul 2026 · Exp Jun 2028 | DescriptionDescription | SDTL, PunjabState lab | Sep 2026 |
| Cefixime Tablets I.P. 200 mg | Batch T6227Mfg Jul 2026 · Exp Jun 2028 | DescriptionDescription | SDTL, PunjabState lab | Sep 2026 |
| Doxycycline Hydrochloride Capsule IP 100 mg | Batch C5009Mfg Jul 2025 · Exp Jun 2027 | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Doxycycline Hydrochloride Capsule IP 100 mg | Batch C5007Mfg Jul 2025 · Exp Jun 2027 | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| CEFADROXIL TABLETS I.P. 500 mg | Batch T2072Mfg Mar 2022 · Exp Feb 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2022 |
| CEFIXIME DISPERSIBLE TABLETS IP 200 MG | Batch T0037Mfg Jan 2020 · Exp Dec 2021 | Disintegration Test and Uniformity of DispersionDisintegration | RDTL ChandigarhCDSCO lab | Sep 2021 |
| Norfloxacin Tablet I.P. 400mg | Batch T-9457Mfg Oct 2019 · Exp Sep 2021 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Apr 2020 |
| Vitamin B-complex Tablet (Prophylactic) NFI (III) | Batch T8605Mfg Dec 2018 · Exp May 2020 | Assay of Vitamin B1Assay | CDTL MumbaiCDSCO lab | Jan 2020 |
| Norfloxacin Tablets IP 400 mg | Batch T8422Mfg Aug 2018 · Exp Jul 2020 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.